MedPath

Comparison of two separate dose of Melatonin as a drug used before anesthesia in cancer patient.

Not Applicable
Completed
Conditions
Health Condition 1: C50-C50- Malignant neoplasms of breastHealth Condition 2: C15-C26- Malignant neoplasms of digestive organsHealth Condition 3: C51-C58- Malignant neoplasms of female genital organsHealth Condition 4: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxHealth Condition 5: C73-C75- Malignant neoplasms of thyroid and other endocrine glandsHealth Condition 6: C64-C68- Malignant neoplasms of urinary tractHealth Condition 7: C43-C44- Melanoma and other malignant neoplasms of skin
Registration Number
CTRI/2018/10/015917
Lead Sponsor
Department of Anesthesiology kidwai Cancer Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

•Patients belonging to ASA physical status Grade I and Grade II.

•Patients consenting for study.

Exclusion Criteria

Refusal, chronic HTN,severe cardiac disease, DM,hepatorenal impairment, psychiatric illness, Asthma, drugs like antiHTN, antipsychotics, antiepileptics. History of allergy to drug.emergency surgery, sleep disorder, obesity,difficult airway

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SEDATION-RAMSAY SEDATION SCALE <br/ ><br>ANXIETY- VISUAL ANALOGUE SCALE <br/ ><br>ORIENTATION-O LOG SCALE <br/ ><br>PSYCHOMOTOR FUNCTION-LETTER CANCELLATION TEST, TRIEGER DOT TESTTimepoint: 90 MINUTES PRIOR TO SURGERY <br/ ><br>JUST BEFORE SURGERY
Secondary Outcome Measures
NameTimeMethod
HEMODYNAMIC RESPONSE TO INTUBATIONTimepoint: IMMEDIATELY AFTER INTUBATION, AND 5, 10, 15MINUTES AFTER IT
© Copyright 2025. All Rights Reserved by MedPath